Circulating tumor cell with neutrophil to lymphocyte ratio in predicting efficacy of advanced gastric cancer
Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 2
Abstract
<b>Objective</b> To investigate the predictive effect of circulating tumor cell (CTC) combined with neutrophil to lymphocyte ratio (NLR) on efficacy of advanced gastric cancer. <b>Methods</b> The clinicopathological data of 36 patients with advanced gastric cancer who received firstline treatment in Jiangning Hospital Affiliated to Nanjing Medical University and Jiangsu Cancer Hospital from June 2022 to January 2023 were collected. The optimal cutoff values of CTC and NLR were calculated using Xtile software, and the patients were divided into high CTC group (CTC>15, n=21) and low CTC group (CTC≤15, n=15), high NLR group (NLR>2.32, n=20) and low NLR group (NLR≤2.32, n=16). COX regression analysis and survival curve were used to analyze the relationship between CTC, NLR and progression free survival (PFS). Receiver operating characteristic (ROC) curves compared the predictive power of CTC, NLR, and the combination in predicting the outcome of advanced gastric cancer. <b>Results</b> Multivariate COX regression analysis showed that CTC (HR=7.441, P=0.045) and NLR (HR=4.690, P=0.011) were associated with PFS in patients with advanced gastric cancer. Patients in CTC group and low NLR group had longer PFS than those in high CTC group and high NLR group, respectively (P<0.01). Patients with both high CTC and high NLR had the shortest PFS (P<0.01). Compared with the singlefactor prediction, the combination of CTC and NLR predicted the efficacy of firstline treatment for advanced gastric cancer best (AUC=0.746). <b>Conclusion</b> CTC and NLR are independent prognostic factors affecting PFS in patients with advanced gastric cancer, and CTC combined with NLR can better predict the efficacy of advanced gastric cancer.
Authors and Affiliations
RUAN Luxi*, GUO Renhong, ZHANG Quan'an, LEI Jing, CHEN Meili, YANG Hui, YUAN Yihang, LI Huizi
Research progress on the clinical application of esketamine
Esketamine is the <i>S</i>-enantiomer of racemic ketamine, which has a similar pharmacological mechanism to ketamine. Esketamine has the advantages of fast onset, fast metabolism, little impact on circulatory and respira...
Symptom clusters in patients with hypertensive cerebral haemorrhage during the acute phase and their correlation with prognostic quality of life
<b>Objective</b> To explore the composition of symptom clusters in the acute phase of patients with hypertensive cerebral haemorrhage and to analyse their correlation with prognostic quality of life. <b>Methods</b> From...
Predictive value of serum actinin-4, TFF1, and TGFBI for the prognosis of patients with primary hepatocellular carcinoma after transarterial chemoembolization
Objective To investigate the predictive value of serum actinin-4, trefoil factor 1 (TFF1), and transforming growth factor-β-induced protein (TGFBI) for the prognosis of patients with primary hepatocellular carcinoma (PHC...
Research progress of esketamine and postoperative delirium
Postoperative delirium (POD) is a common complication in elderly patients after surgery, significantly affecting prognosis and increasing mortality rates. The underlying mechanisms of POD remain unclear, with diverse ris...
Application of artificial intelligence in pain assessment
Artificial intelligence (AI) has been widely applied in the field of clinical medicine, including disease prediction and prevention, health management and monitoring, auxiliary diagnosis and treatment, medical imaging, d...